CLASS II ONGOING Drug recall · Reported 11 Nov 2026 · FDA Enforcement Report

Fludrocortisone Acetate Tablets, USP 0.1mg recalled by AvKARE

AvKARE is recalling Fludrocortisone Acetate Tablets, USP 0.1mg, distributed nationwide in the US. The recall was initiated on 9 Oct 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 48353; Exp. 10/31/2026
NDC50268-330
Quantity recalled8866 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0157-2027
FDA event ID
100126
Recalling firm
AvKARE, Pulaski, TN
Manufacturer
AvPAK
Classification
Class II
Status
Ongoing
Recall initiated
9 Oct 2026
FDA classified
30 Oct 2026
Reported
11 Nov 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

9 Oct 2026Recall initiated by company
30 Oct 2026Classified by FDA+21 days
11 Nov 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for: AvKARE, Pulaski, TN 38748, NDC 50268-330-15

Where it was distributed

U.S. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications

Which lots are affected?

Lot # 48353; Exp. 10/31/2026

Where was it sold?

U.S. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 17 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from AvKARE

All 63
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine HclAvKAREPotency & AssayNationwide
DrugCLASS IIRosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatinAvKAREPotency & AssayNationwide
DrugCLASS IINorgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl EstradiolAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide

Other Fludrocortisone recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIFludrocortisone Acetate Tablets, USP 0.1mg recalledTeva Pharmaceuticals USAPotency & AssayNationwide